Literature DB >> 16822373

Neurocysticercosis.

Vincent C Marconi1, Hector H Garcia, Joel T Katz.   

Abstract

Since international travel has become widespread, clinicians increasingly have been confronted with the diagnosis of symptomatic and incidental neurocysticercosis. The difficulty with managing this disease lies in its varied clinical presentations. The treatment of neurocysticercosis depends upon anatomic locations, stages of cysts, and overall cyst burden. Despite recent clinical and laboratory advances, experts are divided on many key management questions. This article reviews the pathophysiology and experimental data underlying treatment recommendations for this emerging and complex condition.

Entities:  

Year:  2006        PMID: 16822373     DOI: 10.1007/s11908-006-0074-9

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.725


  45 in total

1.  Vaccination of pigs to control human neurocysticercosis.

Authors:  Armando E Gonzalez; Charles G Gauci; Dylan Barber; Robert H Gilman; Victor C W Tsang; Hector H Garcia; Manuela Verastegui; Marshall W Lightowlers
Journal:  Am J Trop Med Hyg       Date:  2005-06       Impact factor: 2.345

2.  Calcified cysticerci provoke perilesional edema and seizures.

Authors:  T E Nash; J Pretell; H H Garcia
Journal:  Clin Infect Dis       Date:  2001-10-05       Impact factor: 9.079

3.  The clinical spectrum of neurocysticercosis in the Uttaranchal region.

Authors:  A Varma; K J B S Gaur
Journal:  J Assoc Physicians India       Date:  2002-11

4.  Serodiagnosis of neurocysticercosis using synthetic 8-kD proteins: comparison of assay formats.

Authors:  Christina M Scheel; Azra Khan; Kathy Hancock; Hector H Garcia; Armando E Gonzalez; Robert H Gilman; Victor C W Tsang
Journal:  Am J Trop Med Hyg       Date:  2005-10       Impact factor: 2.345

5.  Albendazole versus praziquantel in the treatment of cerebral cysticercosis: clinical evaluation.

Authors:  M Cruz; I Cruz; J Horton
Journal:  Trans R Soc Trop Med Hyg       Date:  1991 Mar-Apr       Impact factor: 2.184

Review 6.  Imaging findings in neurocysticercosis.

Authors:  Héctor H García; Oscar H Del Brutto
Journal:  Acta Trop       Date:  2003-06       Impact factor: 3.112

7.  Corticosteroids versus albendazole for treatment of single small enhancing computed tomographic lesions in children with neurocysticercosis.

Authors:  Pratibha Singhi; Vivek Jain; Narendra Khandelwal
Journal:  J Child Neurol       Date:  2004-05       Impact factor: 1.987

8.  Sequential expression of the neuropeptides substance P and somatostatin in granulomas associated with murine cysticercosis.

Authors:  Prema Robinson; A Clinton White; Dorothy E Lewis; John Thornby; Elliott David; Joel Weinstock
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

Review 9.  Extraparenchymal neurocysticercosis: report of five cases and review of management.

Authors:  J C Bandres; A C White; T Samo; E C Murphy; R L Harris
Journal:  Clin Infect Dis       Date:  1992-11       Impact factor: 9.079

10.  Effects of prednisone on ventriculoperitoneal shunt function in hydrocephalus secondary to cysticercosis: a preliminary study.

Authors:  R A Suastegui Roman; J L Soto-Hernandez; J Sotelo
Journal:  J Neurosurg       Date:  1996-04       Impact factor: 5.115

View more
  4 in total

1.  The highly antigenic 53/25 kDa Taenia solium protein fraction with cathepsin-L like activity is present in the oncosphere/cysticercus and induces non-protective IgG antibodies in pigs.

Authors:  Mirko Zimic; Mónica Pajuelo; Robert H Gilman; Andrés H Gutiérrez; Luis D Rueda; Myra Flores; Nancy Chile; Manuela Verástegui; Armando Gonzalez; Héctor H García; Patricia Sheen
Journal:  Vet Immunol Immunopathol       Date:  2011-11-11       Impact factor: 2.046

2.  Partial reverse of the TCA cycle is enhanced in Taenia crassiceps experimental neurocysticercosis after in vivo treatment with anthelminthic drugs.

Authors:  Leticia de Almeida Leandro; Carolina Miguel Fraga; Ruy de Souza Lino; Marina Clare Vinaud
Journal:  Parasitol Res       Date:  2014-01-31       Impact factor: 2.289

3.  Serologic diagnosis of human Taenia solium cysticercosis by using recombinant and synthetic antigens in QuickELISA™.

Authors:  Yeuk-Mui Lee; Sukwan Handali; Kathy Hancock; Sowmya Pattabhi; Victor A Kovalenko; Andrew Levin; Silvia Rodriguez; Sehching Lin; Christina M Scheel; Armando E Gonzalez; Robert H Gilman; Hector H Garcia; Victor C W Tsang
Journal:  Am J Trop Med Hyg       Date:  2011-04       Impact factor: 2.345

4.  Commentary.

Authors:  Mehrdad Emami
Journal:  J Neurosci Rural Pract       Date:  2015 Jul-Sep
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.